EP Patent

EP2303228B1 — Fosphenytoin composition

Assigned to Texcontor · Expires 2011-11-30 · 14y expired

What this patent protects

The invention relates to an aqueous pharmaceutical composition comprising 5, 5-diphenyl-3- [ (phosphonooxy) methyl] -2, 4-imidazolidinedione or a salt thereof, said composition having a pH of less than 8.3.

USPTO Abstract

The invention relates to an aqueous pharmaceutical composition comprising 5, 5-diphenyl-3- [ (phosphonooxy) methyl] -2, 4-imidazolidinedione or a salt thereof, said composition having a pH of less than 8.3.

Drugs covered by this patent

Patent Metadata

Patent number
EP2303228B1
Jurisdiction
EP
Classification
—
Expires
2011-11-30
Drug substance claim
No
Drug product claim
No
Assignee
Texcontor
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.